These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 1361821

  • 21. Mineral metabolism and renal bone disease: effects of CAPD versus hemodialysis.
    Coburn JW.
    Kidney Int Suppl; 1993 Feb; 40():S92-100. PubMed ID: 8445845
    [No Abstract] [Full Text] [Related]

  • 22. Reversal of aluminum-related bone disease after substituting calcium carbonate for aluminum hydroxide.
    Hercz G, Andress DL, Nebeker HG, Shinaberger JH, Sherrard DJ, Coburn JW.
    Am J Kidney Dis; 1988 Jan; 11(1):70-5. PubMed ID: 3337101
    [Abstract] [Full Text] [Related]

  • 23. Spectrum of renal osteodystrophy in children on continuous ambulatory peritoneal dialysis.
    Yalçinkaya F, Ince E, Tümer N, Ensari A, Ozkaya N.
    Pediatr Int; 2000 Feb; 42(1):53-7. PubMed ID: 10703235
    [Abstract] [Full Text] [Related]

  • 24. The pathogenesis of renal osteodystrophy: role of vitamin D, aluminium, parathyroid hormone, calcium and phosphorus.
    Dunstan CR, Hills E, Norman AW, Bishop JE, Mayer E, Wong SY, Johnson JR, George CR, Collett P, Kalowski S.
    Q J Med; 1985 May; 55(217):127-44. PubMed ID: 4001311
    [Abstract] [Full Text] [Related]

  • 25. Renal osteodystrophy in children undergoing continuous ambulatory peritoneal dialysis.
    Hewitt IK, Stefanidis C, Reilly BJ, Kooh SW, Balfe JW.
    J Pediatr; 1983 Nov; 103(5):729-34. PubMed ID: 6631599
    [Abstract] [Full Text] [Related]

  • 26. The clinical spectrum of renal osteodystrophy in 57 chronic hemodialysis patients: a correlation between biochemical parameters and bone pathology findings.
    Chazan JA, Libbey NP, London MR, Pono L, Abuelo JG.
    Clin Nephrol; 1991 Feb; 35(2):78-85. PubMed ID: 2019018
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The role of DEXA bone densitometry in evaluating renal osteodystrophy in continuous ambulatory peritoneal dialysis patients.
    Johnson DW, McIntyre HD, Brown A, Freeman J, Rigby RJ.
    Perit Dial Int; 1996 Feb; 16(1):34-40. PubMed ID: 8616170
    [Abstract] [Full Text] [Related]

  • 29. Low-calcium dialysis fluid and oral calcium carbonate in CAPD. A method of controlling hyperphosphataemia whilst minimizing aluminium exposure and hypercalcaemia.
    Hutchison AJ, Freemont AJ, Boulton HF, Gokal R.
    Nephrol Dial Transplant; 1992 Feb; 7(12):1219-25. PubMed ID: 1337163
    [Abstract] [Full Text] [Related]

  • 30. Renal osteodystrophy in CAPD patients.
    Zucchelli P, Catizone L, Casanova S, Fusaroli M, Fabbri L, Ferrari G.
    Miner Electrolyte Metab; 1984 Feb; 10(5):326-32. PubMed ID: 6493161
    [Abstract] [Full Text] [Related]

  • 31. Interpretation of serum aluminum values in dialysis patients.
    McCarthy JT, Milliner DS, Kurtz SB, Johnson WJ, Moyer TP.
    Am J Clin Pathol; 1986 Nov; 86(5):629-36. PubMed ID: 3776914
    [Abstract] [Full Text] [Related]

  • 32. [A pathological analysis of 51 cases of renal osteodystrophy].
    Yu YF, Hu YX, Zhu P.
    Zhonghua Nei Ke Za Zhi; 1993 Jul; 32(7):448-50. PubMed ID: 8275821
    [Abstract] [Full Text] [Related]

  • 33. Adynamic bone and chronic renal failure: an overview.
    Cannata Andía JB.
    Am J Med Sci; 2000 Aug; 320(2):81-4. PubMed ID: 10981480
    [Abstract] [Full Text] [Related]

  • 34. Serum concentration and peritoneal transfer of aluminum during treatment by continuous ambulatory peritoneal dialysis.
    Rottembourg J, Gallego JL, Jaudon MC, Clavel JP, Legrain M.
    Kidney Int; 1984 Jun; 25(6):919-24. PubMed ID: 6471674
    [Abstract] [Full Text] [Related]

  • 35. Association between fluoride, magnesium, aluminum and bone quality in renal osteodystrophy.
    Ng AH, Hercz G, Kandel R, Grynpas MD.
    Bone; 2004 Jan; 34(1):216-24. PubMed ID: 14751580
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Control of mineral metabolism in CAPD patients.
    Delmez JA.
    Blood Purif; 1989 Jan; 7(2-3):167-80. PubMed ID: 2663036
    [Abstract] [Full Text] [Related]

  • 38. [Pathological analysis of renal osteodystrophy in 194 cases].
    Yu YF.
    Zhonghua Bing Li Xue Za Zhi; 1991 Dec; 20(4):280-3. PubMed ID: 1813163
    [Abstract] [Full Text] [Related]

  • 39. Progress of renal osteodystrophy during continuous ambulatory peritoneal dialysis.
    Buccianti G, Bianchi ML, Valenti G.
    Clin Nephrol; 1984 Dec; 22(6):279-83. PubMed ID: 6525771
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.